Zoetis Inc. (ZTS): Price and Financial Metrics

ZTS POWR Grades

• ZTS scores best on the Quality dimension, with a Quality rank ahead of 94.66% of US stocks.
• The strongest trend for ZTS is in Momentum, which has been heading down over the past 48 weeks.
• ZTS's current lowest rank is in the Momentum metric (where it is better than 55.81% of US stocks).

ZTS Stock Summary

• ZTS has a market capitalization of $97,021,115,749 -- more than approximately 97.38% of US stocks.
• ZTS's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 269.4 -- higher than 89.18% of US-listed equities with positive expected earnings growth.
• The price/operating cash flow metric for Zoetis Inc is higher than 89.62% of stocks in our set with a positive cash flow.
• If you're looking for stocks that are quantitatively similar to Zoetis Inc, a group of peers worth examining would be MMM, SYK, CAT, GE, and BDX.
• Visit ZTS's SEC page to see the company's official filings. To visit the company's web site, go to www.zoetis.com.

ZTS Valuation Summary

• In comparison to the median Healthcare stock, ZTS's EV/EBIT ratio is 33.45% higher, now standing at 39.1.
• ZTS's price/sales ratio has moved up 9.4 over the prior 104 months.
• Over the past 104 months, ZTS's price/earnings ratio has gone down 12.5.

Below are key valuation metrics over time for ZTS.

ZTS Growth Metrics

• The 3 year price growth rate now stands at 117.89%.
• Its 4 year cash and equivalents growth rate is now at 189.04%.
• Its 5 year revenue growth rate is now at 31.76%.

ZTS's revenue has moved up $1,073,000,000 over the prior 15 months.

The table below shows ZTS's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	7,412	2,161	1,909
2021-03-31	7,012	2,118	1,774
2020-12-31	6,675	2,126	1,638
2020-09-30	6,542	1,990	1,663
2020-06-30	6,340	1,934	1,617
2020-03-31	6,339	1,814	1,611

ZTS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ZTS has a Quality Grade of B, ranking ahead of 94.64% of graded US stocks.
• ZTS's asset turnover comes in at 0.537 -- ranking 74th of 677 Pharmaceutical Products stocks.
• GERN, CEMI, and NEOG are the stocks whose asset turnover ratios are most correlated with ZTS.

The table below shows ZTS's key quality metrics over time.